Who owns the SCRIBE THERAPEUTICS trademark?

The SCRIBE THERAPEUTICS trademark is owned by Scribe Therapeutics Inc..

What class is the SCRIBE THERAPEUTICS trademark registered in?

The SCRIBE THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for SCRIBE THERAPEUTICS?

The USPTO serial number for SCRIBE THERAPEUTICS is 97420511.

What is the registration number for SCRIBE THERAPEUTICS?

SCRIBE THERAPEUTICS is registered under USPTO registration number 8340317.

Sealvo

Home Search: SCRIBE THERAPEUTICSSCRIBE THERAPEUTICS #97420511

Back

Updated Sep 29, 2026·38 searches this week

View on USPTO TSDR Find similar marks

SCR

USPTO Trademark Record

REGISTERED

SCRIBE THERAPEUTICS

SN 97420511·Reg 8340317·Filed May 20, 2022

Owner Scribe Therapeutics Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

SCRIBE THERAPEUTICS (Serial No. 97420511), Registration No. 8340317, is a registered US trademark filed on May 20, 2022 by Scribe Therapeutics Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: July 14, 2032

Conflict Analysis

Full conflict analysis for SCRIBE THERAPEUTICS (SN 97420511) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

SCRIBE THERAPEUTICS (Reg. #8340317) is a registered US trademark that has been protecting its owner, Scribe Therapeutics Inc., since 2022. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

May 20, 2022

SERIAL

97420511

REG#

8340317

REGISTERED

Jul 14, 2026

Filing Information

StatusREGISTERED

Filing DateMay 20, 2022

Serial Number97420511

Registration No.8340317

Registration DateJul 14, 2026

Status DateJul 14, 2026

Published for OppositionApr 25, 2023

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application Currently

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Oct 01, 2020

First use in commerce: Oct 01, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

38 events

REGISTERED-PRINCIPAL REGISTER

Jul 14, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jul 14, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

1(B) BASIS DELETED; PROCEED TO REGISTRATION

Jun 22, 2026

1(B) BASIS DELETED; PROCEED TO REGISTRATION

TEAS POST PUBLICATION AMENDMENT RECEIVED

Jun 20, 2026

TEAS POST PUBLICATION AMENDMENT RECEIVED

NOTICE OF ALLOWANCE CANCELLED

Jun 20, 2026

NOTICE OF ALLOWANCE CANCELLED

SOU EXTENSION 5 GRANTED

Dec 15, 2025

SOU EXTENSION 5 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 15, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Dec 14, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Dec 14, 2025

SOU EXTENSION 5 FILED

SOU EXTENSION 4 GRANTED

Dec 09, 2025

SOU EXTENSION 4 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 09, 2025

CASE ASSIGNED TO INTENT TO USE PARALEGAL

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 09, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 4 FILED

Jun 18, 2025

SOU EXTENSION 4 FILED

SOU TEAS EXTENSION RECEIVED

Jun 18, 2025

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 03, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Dec 15, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Dec 15, 2024

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Dec 15, 2024

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 13, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Jun 11, 2024

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Jun 11, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jun 11, 2024

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 12, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Dec 10, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Dec 10, 2023

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Dec 10, 2023

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jun 20, 2023

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Apr 25, 2023

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Apr 25, 2023

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 05, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Mar 16, 2023

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 16, 2023

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 16, 2023

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 16, 2023

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 16, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Mar 09, 2023

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 25, 2022

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

May 24, 2022

NEW APPLICATION ENTERED

Other Marks by Scribe Therapeutics Inc.

Additional USPTO filings from the same owner.

XSC

X SCRIBE THERAPEUTICS

97473474

Scribe Therapeutics Inc.

REGISTERED

CRI

CRISPR BY DESIGN

90981354

Scribe Therapeutics Inc.

REGISTERED

SCR

SCRIBE

88188800

Scribe Therapeutics Inc.

REGISTERED

SCR

SCRIBE THERAPEUTICS

50024118

Scribe Therapeutics Inc.

PENDING

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

XSC

X SCRIBE THERAPEUTICS

97473474

Scribe Therapeutics Inc.

REGISTERED

SCR

SCRIBE

87181239

CLOUD SOFTWARE GROUP, INC.

REGISTERED

SCR

SCRIBE.

97395968

Scribe SAS

REGISTERED

SCR

SCRIBE

97098100

f8 Real Estate Media, LLC

REGISTERED

Other Marks by John Paul Oleksiuk

Additional USPTO filings handled by the same attorney of record.

BIT

BITTERROOTBIO

98651562

REGISTERED

GEN

GENIES & GEMS

86748978

REGISTERED

AMP

AMPATHY

86761779

REGISTERED

NOT

NOTABLE CAPITAL

98406930

REGISTERED

SCRIBE THERAPEUTICS

Run a conflict check

Other Marks by Scribe Therapeutics Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by John Paul Oleksiuk

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company